Germline variation at 8q24 and prostate cancer risk in men of European ancestry

dc.contributor.authorMatejcic M
dc.contributor.authorSaunders EJ
dc.contributor.authorDadaev T
dc.contributor.authorBrook MN
dc.contributor.authorWang K
dc.contributor.authorSheng X
dc.contributor.authorAl Olama AA
dc.contributor.authorSchumacher FR
dc.contributor.authorIngles SA
dc.contributor.authorGovindasami K
dc.contributor.authorBenlloch S
dc.contributor.authorBerndt SI
dc.contributor.authorAlbanes D
dc.contributor.authorKoutros S
dc.contributor.authorMuir K
dc.contributor.authorStevens VL
dc.contributor.authorGapstur SM
dc.contributor.authorTangen CM
dc.contributor.authorBatra J
dc.contributor.authorClements J
dc.contributor.authorGronberg H
dc.contributor.authorPashayan N
dc.contributor.authorSchleutker J
dc.contributor.authorWolk A
dc.contributor.authorWest C
dc.contributor.authorMucci L
dc.contributor.authorKraft P
dc.contributor.authorCancel-Tassin G
dc.contributor.authorSorensen KD
dc.contributor.authorMaehle L
dc.contributor.authorGrindedal EM
dc.contributor.authorStrom SS
dc.contributor.authorNeal DE
dc.contributor.authorHamdy FC
dc.contributor.authorDonovan JL
dc.contributor.authorTravis RC
dc.contributor.authorHamilton RJ
dc.contributor.authorRosenstein B
dc.contributor.authorLu YJ
dc.contributor.authorGiles GG
dc.contributor.authorKibel AS
dc.contributor.authorVega A
dc.contributor.authorBensen JT
dc.contributor.authorKogevinas M
dc.contributor.authorPenney KL
dc.contributor.authorPark JY
dc.contributor.authorStanford JL
dc.contributor.authorCybulski C
dc.contributor.authorNordestgaard BG
dc.contributor.authorBrenner H
dc.contributor.authorMaier C
dc.contributor.authorKim J
dc.contributor.authorTeixeira MR
dc.contributor.authorNeuhausen SL
dc.contributor.authorDe Ruyck K
dc.contributor.authorRazack A
dc.contributor.authorNewcomb LF
dc.contributor.authorLessel D
dc.contributor.authorKaneva R
dc.contributor.authorUsmani N
dc.contributor.authorClaessens F
dc.contributor.authorTownsend PA
dc.contributor.authorDominguez MG
dc.contributor.authorRoobol MJ
dc.contributor.authorMenegaux F
dc.contributor.authorKhaw KT
dc.contributor.authorCannon-Albright LA
dc.contributor.authorPandha H
dc.contributor.authorThibodeau SN
dc.contributor.authorSchaid DJ
dc.contributor.authorWiklund F
dc.contributor.authorChanock SJ
dc.contributor.authorEaston DF
dc.contributor.authorEeles RA
dc.contributor.authorKote-Jarai Z
dc.contributor.authorConti DV
dc.contributor.authorHaiman CA
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id37023883
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/37023883
dc.date.accessioned2022-10-28T14:19:37Z
dc.date.available2022-10-28T14:19:37Z
dc.description.abstractChromosome 8q24 is a susceptibility locus for multiple cancers, including prostate cancer. Here we combine genetic data across the 8q24 susceptibility region from 71,535 prostate cancer cases and 52,935 controls of European ancestry to define the overall contribution of germline variation at 8q24 to prostate cancer risk. We identify 12 independent risk signals for prostate cancer (p < 4.28 x 10(-15)), including three risk variants that have yet to be reported. From a polygenic risk score (PRS) model, derived to assess the cumulative effect of risk variants at 8q24, men in the top 1% of the PRS have a 4-fold (95% CI = 3.62-4.40) greater risk compared to the population average. These 12 variants account for similar to 25% of what can be currently explained of the familial risk of prostate cancer by known genetic risk factors. These findings highlight the overwhelming contribution of germline variation at 8q24 on prostate cancer risk which has implications for population risk stratification.
dc.format.pagerange1
dc.format.pagerange11
dc.identifier.jour-issn2041-1723
dc.identifier.olddbid187613
dc.identifier.oldhandle10024/170707
dc.identifier.urihttps://www.utupub.fi/handle/11111/45006
dc.identifier.urnURN:NBN:fi-fe2021042720337
dc.language.isoen
dc.okm.affiliatedauthorSchleutker, Johanna
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherNATURE PUBLISHING GROUP
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumberARTN 4616
dc.relation.doi10.1038/s41467-018-06863-1
dc.relation.ispartofjournalNature Communications
dc.relation.volume9
dc.source.identifierhttps://www.utupub.fi/handle/10024/170707
dc.titleGermline variation at 8q24 and prostate cancer risk in men of European ancestry
dc.year.issued2018

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s41467-018-06863-1.pdf
Size:
1.58 MB
Format:
Adobe Portable Document Format
Description:
Publisher's version